Summary

Market Overview
The Global Nucleic Acid Sample Preparation Market was valued at USD 2.65 Billion in 2024 and is projected to reach USD 3.86 Billion by 2030, growing at a CAGR of 6.45% during the forecast period. This market plays a vital role in the life sciences and diagnostics industry by enabling the efficient extraction, purification, and preparation of DNA and RNA from various biological sources. Market growth is fueled by the increasing application of molecular diagnostics, the expansion of genomic research, and the global shift toward personalized medicine. As laboratories worldwide demand more efficient and scalable workflows, companies are investing in automation, innovation, and strategic collaborations to deliver high-throughput solutions that address the needs of both clinical and research environments.
Key Market Drivers
Increased Use of Nucleic Acid Testing in Infectious Disease Management
The expanding use of nucleic acid-based testing for infectious disease management is a primary growth driver in the market. Nucleic acid tests (NATs), including RT-PCR, are now central to disease surveillance and diagnostics due to their sensitivity and accuracy. This shift from traditional diagnostic techniques has increased demand for reliable nucleic acid preparation products. According to data from the Institute for Health Metrics and Evaluation, 85 pathogens were responsible for 704 million disability-adjusted life years (DALYs) in 2019, highlighting the vast global disease burden and the urgent need for precise molecular diagnostics. During the COVID-19 pandemic, the importance of rapid viral RNA extraction was underscored, leading to a global uptick in demand for sample preparation kits and systems. This growing reliance on NATs in public health, hospital labs, and point-of-care settings continues to propel market demand for advanced sample prep technologies.
Key Market Challenges
High Cost of Advanced Sample Preparation Technologies
One of the core challenges in this market is the high cost associated with advanced nucleic acid preparation technologies. Automated systems, next-generation sequencing (NGS) compatible platforms, and specialized consumables can impose significant financial burdens on laboratories. These costs hinder the widespread adoption of such technologies, especially in low- and middle-income countries where healthcare budgets are limited. As a result, many laboratories may opt for manual or lower-cost alternatives, restricting the market’s reach and delaying the broader implementation of molecular diagnostics and precision medicine.
Key Market Trends
Integration of Automation and High-Throughput Systems
The integration of automation and high-throughput technologies is a defining trend within the nucleic acid sample preparation market. Automated systems streamline complex workflows, increase throughput, and reduce human error, making them essential in clinical diagnostics and research applications. These platforms, often powered by robotics and AI-driven software, enable laboratories to handle larger volumes of samples efficiently. Automation also enhances reproducibility and consistency in results, which is vital for applications in genomics, infectious disease testing, and precision medicine. As the cost of automation technology becomes more accessible, its adoption is expected to rise significantly across a range of laboratory settings.
Key Market Players
• BGI Group
• F. Hoffmann-La Roche Ltd
• Danaher Corporation
• Eppendorf SE
• BIONEER CORPORATION
• Endress+Hauser Group Services AG
• Merck KGaA
• Norgen Biotek Corp.
• Aurora Biomed Inc.
• Agilent Technologies, Inc.
Report Scope:
In this report, the Global Nucleic Acid Sample Preparation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
• Nucleic Acid Sample Preparation Market, By Product:
o Consumables
o Systems
o Accessories & Components
• Nucleic Acid Sample Preparation Market, By Technology:
o Spin-Column Based Technology
o Magnetic-Bead Based Technology
o Others
• Nucleic Acid Sample Preparation Market, By Therapeutics Area:
o Oncology
o Infectious Disease
o Human Genetics/Population Genetics
o Others
• Nucleic Acid Sample Preparation Market, By Application:
o Genomics
o Proteomics
o Others
• Nucleic Acid Sample Preparation Market, By End User:
o Academic and Research Institutions
o Pharmaceutical and Biotechnology Companies
o Clinical and Diagnostic Laboratories
o Other
• Nucleic Acid Sample Preparation Market, By Region:
o North America
§ United States
§ Canada
§ Mexico
o Europe
§ France
§ United Kingdom
§ Italy
§ Germany
§ Spain
o Asia-Pacific
§ China
§ India
§ Japan
§ Australia
§ South Korea
o South America
§ Brazil
§ Argentina
§ Colombia
o Middle East & Africa
§ South Africa
§ Saudi Arabia
§ UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Nucleic Acid Sample Preparation Market.
Available Customizations:
Global Nucleic Acid Sample Preparation market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).

ページTOPに戻る

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Nucleic Acid Sample Preparation Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Consumables, Systems, Accessories & Components)
5.2.2. By Technology (Spin-Column Based Technology, Magnetic-Bead Based Technology, Others)
5.2.3. By Therapeutic Area (Oncology, Infectious Disease, Human Genetics/Population Genetics, Others)
5.2.4. By Application (Genomics, Proteomics, Others)
5.2.5. By End User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Other)
5.2.6. By Region
5.2.7. By Company (2024)
5.3. Market Map
6. North America Nucleic Acid Sample Preparation Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Technology
6.2.3. By Therapeutics Area
6.2.4. By Application
6.2.5. By End User
6.2.6. By Country
6.3. North America: Country Analysis
6.3.1. United States Nucleic Acid Sample Preparation Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Technology
6.3.1.2.3. By Therapeutics Area
6.3.1.2.4. By Application
6.3.1.2.5. By End User
6.3.2. Canada Nucleic Acid Sample Preparation Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Technology
6.3.2.2.3. By Therapeutics Area
6.3.2.2.4. By Application
6.3.2.2.5. By End User
6.3.3. Mexico Nucleic Acid Sample Preparation Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Technology
6.3.3.2.3. By Therapeutics Area
6.3.3.2.4. By Application
6.3.3.2.5. By End User
7. Europe Nucleic Acid Sample Preparation Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Technology
7.2.3. By Therapeutics Area
7.2.4. By Application
7.2.5. By End User
7.2.6. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Nucleic Acid Sample Preparation Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Technology
7.3.1.2.3. By Therapeutics Area
7.3.1.2.4. By Application
7.3.1.2.5. By End User
7.3.2. United Kingdom Nucleic Acid Sample Preparation Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Technology
7.3.2.2.3. By Therapeutics Area
7.3.2.2.4. By Application
7.3.2.2.5. By End User
7.3.3. Italy Nucleic Acid Sample Preparation Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Technology
7.3.3.2.3. By Therapeutics Area
7.3.3.2.4. By Application
7.3.3.2.5. By End User
7.3.4. France Nucleic Acid Sample Preparation Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Technology
7.3.4.2.3. By Therapeutics Area
7.3.4.2.4. By Application
7.3.4.2.5. By End User
7.3.5. Spain Nucleic Acid Sample Preparation Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Technology
7.3.5.2.3. By Therapeutics Area
7.3.5.2.4. By Application
7.3.5.2.5. By End User
8. Asia-Pacific Nucleic Acid Sample Preparation Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Technology
8.2.3. By Therapeutics Area
8.2.4. By Application
8.2.5. By End User
8.2.6. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Nucleic Acid Sample Preparation Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Technology
8.3.1.2.3. By Therapeutics Area
8.3.1.2.4. By Application
8.3.1.2.5. By End User
8.3.2. India Nucleic Acid Sample Preparation Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Technology
8.3.2.2.3. By Therapeutics Area
8.3.2.2.4. By Application
8.3.2.2.5. By End User
8.3.3. Japan Nucleic Acid Sample Preparation Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Technology
8.3.3.2.3. By Therapeutics Area
8.3.3.2.4. By Application
8.3.3.2.5. By End User
8.3.4. South Korea Nucleic Acid Sample Preparation Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Technology
8.3.4.2.3. By Therapeutics Area
8.3.4.2.4. By Application
8.3.4.2.5. By End User
8.3.5. Australia Nucleic Acid Sample Preparation Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Technology
8.3.5.2.3. By Therapeutics Area
8.3.5.2.4. By Application
8.3.5.2.5. By End User
9. South America Nucleic Acid Sample Preparation Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Technology
9.2.3. By Therapeutics Area
9.2.4. By Application
9.2.5. By End User
9.2.6. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Nucleic Acid Sample Preparation Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Technology
9.3.1.2.3. By Therapeutics Area
9.3.1.2.4. By Application
9.3.1.2.5. By End User
9.3.2. Argentina Nucleic Acid Sample Preparation Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Technology
9.3.2.2.3. By Therapeutics Area
9.3.2.2.4. By Application
9.3.2.2.5. By End User
9.3.3. Colombia Nucleic Acid Sample Preparation Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Technology
9.3.3.2.3. By Therapeutics Area
9.3.3.2.4. By Application
9.3.3.2.5. By End User
10. Middle East and Africa Nucleic Acid Sample Preparation Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Technology
10.2.3. By Therapeutics Area
10.2.4. By Application
10.2.5. By End User
10.2.6. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Nucleic Acid Sample Preparation Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Technology
10.3.1.2.3. By Therapeutics Area
10.3.1.2.4. By Application
10.3.1.2.5. By End User
10.3.2. Saudi Arabia Nucleic Acid Sample Preparation Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Technology
10.3.2.2.3. By Therapeutics Area
10.3.2.2.4. By Application
10.3.2.2.5. By End User
10.3.3. UAE Nucleic Acid Sample Preparation Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Technology
10.3.3.2.3. By Therapeutics Area
10.3.3.2.4. By Application
10.3.3.2.5. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions
13. Global Nucleic Acid Sample Preparation Market: SWOT Analysis
14. Competitive Landscape
14.1. BGI Group
14.1.1. Business Overview
14.1.2. Product & Service Offerings
14.1.3. Recent Developments
14.1.4. Financials (If Listed)
14.1.5. Key Personnel
14.1.6. SWOT Analysis
14.2. F. Hoffmann-La Roche Ltd
14.3. Danaher Corporation
14.4. Eppendorf SE
14.5. BIONEER CORPORATION
14.6. Endress+Hauser Group Services AG
14.7. Merck KGaA
14.8. Norgen Biotek Corp.
14.9. Aurora Biomed Inc.
14.10.Agilent Technologies, Inc.
15. Strategic Recommendations
16. About Us & Disclaimer